|
MMAA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18804965865138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.97351074055541E-12 |
| Normal-vs-Stage2 |
1.42670000258249E-08 |
| Normal-vs-Stage3 |
1.79611880923858E-12 |
| Normal-vs-Stage4 |
8.43436431807731E-13 |
| Stage1-vs-Stage2 |
8.995200E-01 |
| Stage1-vs-Stage3 |
7.462300E-02 |
| Stage1-vs-Stage4 |
6.794400E-02 |
| Stage2-vs-Stage3 |
3.558400E-01 |
| Stage2-vs-Stage4 |
2.398400E-01 |
| Stage3-vs-Stage4 |
6.595600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98918659322089E-12 |
| Normal-vs-AfricanAmerican |
4.13910000000017E-05 |
| Normal-vs-Asian |
9.09869957155252E-11 |
| Caucasian-vs-AfricanAmerican |
1.900820E-01 |
| Caucasian-vs-Asian |
8.298800E-01 |
| AfricanAmerican-vs-Asian |
3.526800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73638881051374E-12 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
7.880000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63402624764331E-12 |
| Normal-vs-Age(41-60Yrs) |
4.04454247870945E-13 |
| Normal-vs-Age(61-80Yrs) |
1.79667392075089E-12 |
| Normal-vs-Age(81-100Yrs) |
5.378900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.220600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.017800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.462400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.939200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.571000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.989600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.103000E-01 |
| Classical-VS-Follicular |
7.563400E-01 |
| Classical-VS-Other |
6.316700E-03 |
| Classical-VS-Normal |
1.37380107290141E-11 |
| Tall-VS-Follicular |
4.152600E-01 |
| Tall-VS-Other |
2.172200E-01 |
| Tall-VS-Normal |
9.37599997641314E-11 |
| Follicular-VS-Other |
1.153790E-02 |
| Follicular-VS-Normal |
2.06320516227265E-11 |
| Other-VS-Normal |
1.041200015095E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.35635946918455E-12 |
| N0-vs-N1 |
4.667800E-01 |
|
|
